Cite
HARVARD Citation
Hida, T. et al. (2019). A phase 2 study of lenvatinib in patients with RET fusion-positive lung adenocarcinoma. Lung cancer. pp. 124-130. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hida, T. et al. (2019). A phase 2 study of lenvatinib in patients with RET fusion-positive lung adenocarcinoma. Lung cancer. pp. 124-130. [Online].